| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | TRIO NET1 MYCBP2 DOCK8 ARHGEF15 SBF2 DOCK7 KIAA1755 DOCK6 PREX1 | 1.42e-05 | 231 | 156 | 10 | GO:0005085 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 TRIO NET1 MYCBP2 DOCK8 LRRK2 CHN1 ARHGEF15 SBF2 DOCK7 KIAA1755 DOCK6 PREX1 | 1.79e-04 | 507 | 156 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 TRIO NET1 MYCBP2 DOCK8 LRRK2 CHN1 ARHGEF15 SBF2 DOCK7 KIAA1755 DOCK6 PREX1 | 1.79e-04 | 507 | 156 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | actin binding | MYH10 MYO5A CAMK2B SYNE1 SPTB SPTBN1 LRRK2 ADD3 SYNE2 COBL MACF1 FMNL1 | 3.93e-04 | 479 | 156 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | 4.23e-04 | 227 | 156 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 5.97e-04 | 5 | 156 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 5.97e-04 | 5 | 156 | 2 | GO:0140444 | |
| GeneOntologyBiologicalProcess | nuclear migration | 5.58e-06 | 34 | 157 | 5 | GO:0007097 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | NET1 DOCK8 APC2 CHN1 ARHGEF15 DOCK7 DOCK6 AGRN PREX1 SLC27A4 | 1.83e-05 | 244 | 157 | 10 | GO:0043547 |
| GeneOntologyBiologicalProcess | nucleus localization | 2.05e-05 | 44 | 157 | 5 | GO:0051647 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | NET1 DOCK8 APC2 LRRK2 CHN1 ARHGEF15 DOCK7 DOCK6 AGRN PREX1 SLC27A4 | 5.35e-05 | 335 | 157 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ARHGAP32 MYH10 TRIO MYCBP2 CAMK2B SYNE1 LRRK2 CHN1 DACT1 NEO1 CLIC5 DOCK7 KIAA1755 COBL MACF1 EEF2K AGRN | 5.81e-05 | 748 | 157 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | NRG1 ARHGAP32 HLA-B MYCBP2 CAMK2B SYNE1 HLA-E LRRK2 CHN1 NEO1 COBL MACF1 EEF2K AGRN PREX1 | 7.02e-05 | 612 | 157 | 15 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | NRG1 ARHGAP32 HLA-B MYCBP2 CAMK2B SYNE1 HLA-E LRRK2 CHN1 PLEK2 NEO1 SYNE2 COBL MACF1 EEF2K RP1 AGRN PREX1 | 8.11e-05 | 846 | 157 | 18 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | NRG1 ARHGAP32 HLA-B MYCBP2 CAMK2B SYNE1 HLA-E LRRK2 CHN1 PLEK2 NEO1 SYNE2 COBL MACF1 EEF2K RP1 AGRN PREX1 | 1.04e-04 | 863 | 157 | 18 | GO:0031344 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | NET1 DOCK8 APC2 WRN CHN1 ARHGEF15 PPARGC1B PTPRC DOCK7 DOCK6 AGRN PREX1 SLC27A4 | 1.19e-04 | 499 | 157 | 13 | GO:0051345 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ARHGAP32 MYH10 TRIO MYCBP2 CAMK2B SYNE1 LRRK2 CHN1 DACT1 NEO1 ZNF335 DOCK7 KIAA1755 COBL MACF1 EEF2K AGRN | 1.35e-04 | 802 | 157 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | positive regulation of vascular associated smooth muscle cell migration | 1.57e-04 | 36 | 157 | 4 | GO:1904754 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ARHGAP32 MYH10 TRIO MYCBP2 CAMK2B SYNE1 LRRK2 CHN1 DACT1 NEO1 ZNF335 DOCK7 KIAA1755 COBL MACF1 EEF2K AGRN | 1.73e-04 | 819 | 157 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ARHGAP32 MYH10 TRIO MYCBP2 CAMK2B SYNE1 LRRK2 CHN1 DACT1 NEO1 ZNF335 DOCK7 KIAA1755 COBL MACF1 EEF2K AGRN | 1.92e-04 | 826 | 157 | 17 | GO:0048858 |
| GeneOntologyCellularComponent | lamellipodium membrane | 2.12e-05 | 22 | 159 | 4 | GO:0031258 | |
| GeneOntologyCellularComponent | growth cone | 1.11e-04 | 245 | 159 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | cell cortex | ARHGAP32 MYH10 PCLO SPTB SPTBN1 RYR1 ADD3 CLIC5 COBL MACF1 FMNL1 | 1.32e-04 | 371 | 159 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | site of polarized growth | 1.42e-04 | 253 | 159 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | leading edge membrane | 2.10e-04 | 210 | 159 | 8 | GO:0031256 | |
| GeneOntologyCellularComponent | postsynapse | NRG1 ARHGAP32 MYH10 TRIO MYO5A CAMK2B SYNE1 PCLO SPTB SPTBN1 APC2 LRRK2 RPS27 ARHGEF15 ADD3 DACT1 NEO1 MACF1 EEF2K | 2.76e-04 | 1018 | 159 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.88e-04 | 42 | 159 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | cell leading edge | MYH10 MYO5A DOCK8 SPTBN1 APC2 FRMD4B PLEK2 MTMR6 SYNJ2 SYNE2 COBL MACF1 | 4.57e-04 | 500 | 159 | 12 | GO:0031252 |
| HumanPheno | Vocal cord dysfunction | 2.85e-05 | 57 | 55 | 6 | HP:0031801 | |
| HumanPheno | Vocal cord paralysis | 2.85e-05 | 57 | 55 | 6 | HP:0001605 | |
| HumanPheno | Vocal cord paresis | 2.85e-05 | 57 | 55 | 6 | HP:0001604 | |
| HumanPheno | Weakness of the vocal cords | 2.85e-05 | 57 | 55 | 6 | HP:0001603 | |
| HumanPheno | Food allergy | 4.18e-05 | 19 | 55 | 4 | HP:0500093 | |
| HumanPheno | Abnormal vocal cord morphology | 4.22e-05 | 61 | 55 | 6 | HP:0008777 | |
| Domain | Spectrin | 2.77e-08 | 23 | 156 | 6 | PF00435 | |
| Domain | Spectrin_repeat | 1.25e-07 | 29 | 156 | 6 | IPR002017 | |
| Domain | SPEC | 2.34e-07 | 32 | 156 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.34e-07 | 32 | 156 | 6 | IPR018159 | |
| Domain | ACTININ_2 | 1.14e-06 | 23 | 156 | 5 | PS00020 | |
| Domain | ACTININ_1 | 1.14e-06 | 23 | 156 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.14e-06 | 23 | 156 | 5 | IPR001589 | |
| Domain | DUF3398 | 1.12e-05 | 6 | 156 | 3 | PF11878 | |
| Domain | DOCK_C/D_N | 1.12e-05 | 6 | 156 | 3 | IPR021816 | |
| Domain | C2H2_Znf_fam | 4.37e-05 | 24 | 156 | 4 | IPR027775 | |
| Domain | DHR-1_domain | 8.98e-05 | 11 | 156 | 3 | IPR027007 | |
| Domain | DHR_2 | 8.98e-05 | 11 | 156 | 3 | PS51651 | |
| Domain | DHR_1 | 8.98e-05 | 11 | 156 | 3 | PS51650 | |
| Domain | DHR-2 | 8.98e-05 | 11 | 156 | 3 | PF06920 | |
| Domain | DOCK | 8.98e-05 | 11 | 156 | 3 | IPR026791 | |
| Domain | DOCK_C | 8.98e-05 | 11 | 156 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 8.98e-05 | 11 | 156 | 3 | PF14429 | |
| Domain | DHR-2 | 8.98e-05 | 11 | 156 | 3 | IPR027357 | |
| Domain | Myotubularin-like_Pase_dom | 1.94e-04 | 14 | 156 | 3 | IPR010569 | |
| Domain | PPASE_MYOTUBULARIN | 1.94e-04 | 14 | 156 | 3 | PS51339 | |
| Domain | Myotubularin_fam | 1.94e-04 | 14 | 156 | 3 | IPR030564 | |
| Domain | Myotub-related | 1.94e-04 | 14 | 156 | 3 | PF06602 | |
| Domain | RNA_pol_Rpb1_2 | 2.07e-04 | 3 | 156 | 2 | PF00623 | |
| Domain | RNA_pol_asu | 2.07e-04 | 3 | 156 | 2 | IPR000722 | |
| Domain | RNA_pol_N | 2.07e-04 | 3 | 156 | 2 | IPR006592 | |
| Domain | Peptidase_S54_rhomboid_met | 2.07e-04 | 3 | 156 | 2 | IPR017213 | |
| Domain | RNA_pol_Rpb1_1 | 2.07e-04 | 3 | 156 | 2 | PF04997 | |
| Domain | RNA_pol_Rpb1_5 | 2.07e-04 | 3 | 156 | 2 | PF04998 | |
| Domain | RNA_pol_Rpb1_3 | 2.07e-04 | 3 | 156 | 2 | PF04983 | |
| Domain | RNA_pol_Rpb1_4 | 2.07e-04 | 3 | 156 | 2 | PF05000 | |
| Domain | RPOLA_N | 2.07e-04 | 3 | 156 | 2 | SM00663 | |
| Domain | RNA_pol_Rpb1_4 | 2.07e-04 | 3 | 156 | 2 | IPR007083 | |
| Domain | RNA_pol_Rpb1_5 | 2.07e-04 | 3 | 156 | 2 | IPR007081 | |
| Domain | RNA_pol_Rpb1_1 | 2.07e-04 | 3 | 156 | 2 | IPR007080 | |
| Domain | RNA_pol_Rpb1_3 | 2.07e-04 | 3 | 156 | 2 | IPR007066 | |
| Domain | CH | 2.10e-04 | 65 | 156 | 5 | SM00033 | |
| Domain | Guanylate_kinase_CS | 2.96e-04 | 16 | 156 | 3 | IPR020590 | |
| Domain | CH | 2.98e-04 | 70 | 156 | 5 | PF00307 | |
| Domain | GDS_CDC24_CS | 3.07e-04 | 39 | 156 | 4 | IPR001331 | |
| Domain | - | 3.18e-04 | 71 | 156 | 5 | 1.10.418.10 | |
| Domain | CH | 3.62e-04 | 73 | 156 | 5 | PS50021 | |
| Domain | CH-domain | 4.11e-04 | 75 | 156 | 5 | IPR001715 | |
| Domain | KASH | 4.11e-04 | 4 | 156 | 2 | IPR012315 | |
| Domain | KASH | 4.11e-04 | 4 | 156 | 2 | PS51049 | |
| Domain | Spectrin_bsu | 4.11e-04 | 4 | 156 | 2 | IPR016343 | |
| Domain | KASH | 4.11e-04 | 4 | 156 | 2 | SM01249 | |
| Domain | KASH | 4.11e-04 | 4 | 156 | 2 | PF10541 | |
| Domain | Znf_C2H2 | ZNF474 ADNP2 OSR2 ZKSCAN2 ZNF692 ZNF768 TRIM23 ZBTB14 ZNF462 ZBTB49 ZSCAN32 OVOL1 ZSCAN1 ZNF335 PLAGL1 ZNF839 ZNF572 | 4.14e-04 | 805 | 156 | 17 | IPR007087 |
| Domain | Myosin_S1_N | 6.82e-04 | 5 | 156 | 2 | IPR008989 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF474 ADNP2 OSR2 ZKSCAN2 ZNF692 ZNF768 ZBTB14 ZNF462 ZBTB49 ZSCAN32 OVOL1 ZSCAN1 ZNF335 PLAGL1 ZNF839 ZNF572 | 7.83e-04 | 775 | 156 | 16 | PS50157 |
| Domain | SANT | 8.00e-04 | 50 | 156 | 4 | SM00717 | |
| Domain | ZINC_FINGER_C2H2_1 | ZNF474 ADNP2 OSR2 ZKSCAN2 ZNF692 ZNF768 ZBTB14 ZNF462 ZBTB49 ZSCAN32 OVOL1 ZSCAN1 ZNF335 PLAGL1 ZNF839 ZNF572 | 8.04e-04 | 777 | 156 | 16 | PS00028 |
| Domain | GUANYLATE_KINASE_2 | 8.95e-04 | 23 | 156 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 8.95e-04 | 23 | 156 | 3 | PS00856 | |
| Domain | PH_dom-like | TRIO NET1 SPTBN1 PTPN21 FRMD4B ARHGEF15 PLEK2 MTMR6 MTMR11 SBF2 PREX1 | 9.23e-04 | 426 | 156 | 11 | IPR011993 |
| Domain | SANT/Myb | 9.28e-04 | 52 | 156 | 4 | IPR001005 | |
| Domain | MHC_I_a_C | 1.02e-03 | 6 | 156 | 2 | IPR010579 | |
| Domain | MHC_I_C | 1.02e-03 | 6 | 156 | 2 | PF06623 | |
| Domain | Guanylate_kin | 1.29e-03 | 26 | 156 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 1.29e-03 | 26 | 156 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 1.29e-03 | 26 | 156 | 3 | IPR008144 | |
| Domain | GuKc | 1.29e-03 | 26 | 156 | 3 | SM00072 | |
| Domain | DnaJ_domain_CS | 1.44e-03 | 27 | 156 | 3 | IPR018253 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.45e-03 | 99 | 156 | 5 | IPR029021 | |
| Domain | Peptidase_S54_rhomboid | 1.88e-03 | 8 | 156 | 2 | IPR002610 | |
| Domain | DH_1 | 1.90e-03 | 63 | 156 | 4 | PS00741 | |
| Domain | Peptidase_S54_rhomboid_dom | 2.40e-03 | 9 | 156 | 2 | IPR022764 | |
| Domain | Rhomboid | 2.40e-03 | 9 | 156 | 2 | PF01694 | |
| Domain | - | 2.40e-03 | 9 | 156 | 2 | 1.20.1540.10 | |
| Domain | RhoGEF | 2.52e-03 | 68 | 156 | 4 | SM00325 | |
| Domain | Znf_C2H2-like | ADNP2 OSR2 ZKSCAN2 ZNF692 ZNF768 ZBTB14 ZNF462 ZBTB49 ZSCAN32 OVOL1 ZSCAN1 ZNF335 PLAGL1 ZNF839 ZNF572 | 2.77e-03 | 796 | 156 | 15 | IPR015880 |
| Domain | RhoGEF | 2.80e-03 | 70 | 156 | 4 | PF00621 | |
| Domain | DH_2 | 2.80e-03 | 70 | 156 | 4 | PS50010 | |
| Domain | - | 2.95e-03 | 71 | 156 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 2.95e-03 | 71 | 156 | 4 | IPR000219 | |
| Domain | Myb_DNA-binding | 3.08e-03 | 35 | 156 | 3 | PF00249 | |
| Domain | ZnF_C2H2 | ADNP2 OSR2 ZKSCAN2 ZNF692 ZNF768 ZBTB14 ZNF462 ZBTB49 ZSCAN32 OVOL1 ZSCAN1 ZNF335 PLAGL1 ZNF839 ZNF572 | 3.19e-03 | 808 | 156 | 15 | SM00355 |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 7.27e-07 | 94 | 111 | 8 | MM15598 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 3.62e-06 | 155 | 111 | 9 | M41808 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 6.16e-06 | 16 | 111 | 4 | MM15605 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 9.73e-06 | 175 | 111 | 9 | MM15599 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.46e-05 | 184 | 111 | 9 | M41809 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP32 SLC4A7 TRIO NET1 DOCK8 SPTBN1 CHN1 ARHGEF15 ADD3 DOCK7 DOCK6 PREX1 FMNL1 | 4.06e-05 | 439 | 111 | 13 | MM15595 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP32 SLC4A7 TRIO NET1 DOCK8 SPTBN1 CHN1 ARHGEF15 ADD3 DOCK7 DOCK6 PREX1 FMNL1 | 5.24e-05 | 450 | 111 | 13 | M27078 |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 7.03e-05 | 55 | 111 | 5 | M41815 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP32 MYH10 SLC4A7 TRIO NET1 DOCK8 SPTBN1 RPS27 CHN1 ARHGEF15 ADD3 DOCK7 DOCK6 PREX1 FMNL1 | 1.68e-04 | 649 | 111 | 15 | MM15690 |
| Pathway | PID_RAC1_REG_PATHWAY | 2.19e-04 | 38 | 111 | 4 | M241 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP32 MYH10 SLC4A7 TRIO NET1 DOCK8 SPTBN1 RPS27 CHN1 ARHGEF15 ADD3 DOCK7 DOCK6 PREX1 FMNL1 | 5.10e-04 | 720 | 111 | 15 | M41838 |
| Pubmed | TRIO MYCBP2 SYNE1 SPTB SPTBN1 HLA-E OSR2 BRMS1L RYR1 ZNF462 DACT1 NEO1 CLIC5 IGFBP5 ADAMTS9 SYNE2 MACF1 | 1.74e-10 | 497 | 160 | 17 | 23414517 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJB12 MAGI1 MYH10 POLR1A TRIO MYO5A MYCBP2 CAMK2B KIZ SPTB WDR70 ASH1L MAGI3 ARID1A ZNF462 PPARGC1B PWWP2B SYNJ2 SBF2 SETBP1 ARID5B KIAA1328 COBL MACF1 ZNF839 DOCK6 TET3 | 1.08e-09 | 1489 | 160 | 27 | 28611215 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAGI1 ARHGAP32 SLC4A7 TRIO NET1 MYCBP2 CALU SPTBN1 TSSK2 MAGI3 RPS27 PTPN21 SYNJ2 STARD9 SYNE2 DOCK7 MAP3K10 COBL MACF1 DOCK6 | 3.34e-09 | 861 | 160 | 20 | 36931259 |
| Pubmed | DNAJB12 ELOA SLC4A7 POLR1A TRIO MYCBP2 VPS50 WDR70 SLC35E1 FRMD4B COMMD3 MTMR6 NEO1 SYNJ2 SEC23IP NFRKB SLC27A4 MYBL2 | 9.21e-09 | 733 | 160 | 18 | 34672954 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MPP3 TRIO MYCBP2 WDR70 SPATA20 JADE1 ARID1A RYR1 DACT1 PWWP2B OVOL1 ZNF335 SBF2 COBL LRRC14 ZNF839 DOCK6 MYRF AGRN PREX1 MYBL2 | 4.23e-08 | 1105 | 160 | 21 | 35748872 |
| Pubmed | MAGI1 ARHGAP32 MYH10 HLA-B SYNE1 SPTBN1 ADNP2 RPS27 SYNJ2 KIAA1328 MAP3K10 COBL MACF1 ZNF839 | 6.46e-08 | 486 | 160 | 14 | 20936779 | |
| Pubmed | MAGI1 ARHGAP32 MYH10 TRIO MYO5A MYCBP2 CAMK2B SYNE1 SPTBN1 APC2 SPATA20 ZNF462 SYNE2 SEC23IP DOCK7 MACF1 JAKMIP1 AGRN TP53BP1 | 1.10e-07 | 963 | 160 | 19 | 28671696 | |
| Pubmed | HLA-B TRIO MYO5A MYCBP2 SYNE1 SPTB SPTBN1 APC2 ASH1L ADNP2 ABCC5 MAGI3 ARID1A FRMD4B ADD3 ADAMTS9 SEC23IP ARID5B MAP3K10 MACF1 JAKMIP1 PREX1 | 1.21e-07 | 1285 | 160 | 22 | 35914814 | |
| Pubmed | MAGI1 ARHGAP32 TRIO MYO5A NET1 DOCK8 CALU ACLY MAGI3 CHN1 ZNF768 ARHGEF15 MRPS17 DOCK7 COBL DOCK6 PREX1 JPT2 | 2.59e-07 | 916 | 160 | 18 | 32203420 | |
| Pubmed | Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. | 5.66e-07 | 15 | 160 | 4 | 14990792 | |
| Pubmed | ELOA MYH10 ZNF474 MYO5A CAMK2B SYNE1 PCLO SPTBN1 ASH1L ABCC5 MAGI3 MSL1 PTPN21 ARID1A PLEK2 STARD9 SYNE2 SEC23IP MACF1 JAKMIP1 PREX1 SLC27A4 | 8.42e-07 | 1442 | 160 | 22 | 35575683 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MAGI1 NRG1 ARHGAP32 SLC4A7 ABCC5 MSL1 ADD3 PLEK2 NEO1 NRK DOCK7 COBL MYRF | 2.58e-06 | 569 | 160 | 13 | 30639242 |
| Pubmed | Activation by SLAM Family Receptors Contributes to NK Cell Mediated "Missing-Self" Recognition. | 5.26e-06 | 8 | 160 | 3 | 27054584 | |
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 27732841 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SYNE1 ABCC5 MAGI3 EXOSC2 COMMD3 ADD3 ST3GAL5 SYNJ2 SEC23IP COBL MACF1 LRRC14 MYRF AGRN | 6.59e-06 | 719 | 160 | 14 | 35337019 |
| Pubmed | 7.38e-06 | 153 | 160 | 7 | 10718198 | ||
| Pubmed | 7.87e-06 | 9 | 160 | 3 | 11466198 | ||
| Pubmed | ARHGAP32 MYH10 MYO5A CALU SPTBN1 BCORL1 IRF3 MSL1 BRMS1L ARID1A ZNF768 ZBTB14 ZNF462 RPL7L1 MRPS17 SYNE2 ARID5B NFRKB TP53BP1 MYBL2 | 9.93e-06 | 1429 | 160 | 20 | 35140242 | |
| Pubmed | 1.04e-05 | 225 | 160 | 8 | 12168954 | ||
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 1.34e-05 | 233 | 160 | 8 | 32290105 | |
| Pubmed | DNAJB12 SLC4A7 POLR1A MYO5A NET1 SYNE1 WRN SLC35E1 MSL1 ALKBH5 EXOSC2 ZNF768 DNAJC2 RPL7L1 IGFBP5 MRPS17 NFRKB MACF1 AGRN PREX1 | 1.94e-05 | 1497 | 160 | 20 | 31527615 | |
| Pubmed | MYH10 HLA-B MYCBP2 DOCK8 SPTBN1 ASH1L SVEP1 MTMR11 PTPRC MACF1 PLAGL1 FMNL1 | 2.04e-05 | 591 | 160 | 12 | 15231748 | |
| Pubmed | MAGI-1: a widely expressed, alternatively spliced tight junction protein. | 2.10e-05 | 2 | 160 | 2 | 11969287 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11792814 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 2.10e-05 | 2 | 160 | 2 | 24931616 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22837485 | ||
| Pubmed | A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk. | 2.10e-05 | 2 | 160 | 2 | 25990289 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 28209656 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25739938 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22768332 | ||
| Pubmed | B-lineage commitment prior to surface expression of B220 and CD19 on hematopoietic progenitor cells. | 2.10e-05 | 2 | 160 | 2 | 18495958 | |
| Pubmed | Dock8 regulates BCR signaling and activation of memory B cells via WASP and CD19. | 2.10e-05 | 2 | 160 | 2 | 29472447 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 2.10e-05 | 2 | 160 | 2 | 17267447 | |
| Pubmed | A system for reconstructing B cell antigen receptor signaling in the mouse myeloma J558L cell line. | 2.10e-05 | 2 | 160 | 2 | 23454348 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 2.10e-05 | 2 | 160 | 2 | 24718612 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24586179 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 38114747 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 33712709 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 17761684 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 31578382 | ||
| Pubmed | Identification of mNET1 as a candidate ligand for the first PDZ domain of MAGI-1. | 2.10e-05 | 2 | 160 | 2 | 11350080 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34315861 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24716975 | ||
| Pubmed | 2.64e-05 | 13 | 160 | 3 | 21177258 | ||
| Pubmed | ELOA ARHGAP32 MYH10 TRIO MYO5A MYCBP2 CALU SPTBN1 PTPN21 ARID1A MTMR6 MTMR11 PTPRC SBF2 SYNE2 KIAA1328 | 2.94e-05 | 1049 | 160 | 16 | 27880917 | |
| Pubmed | 3.35e-05 | 14 | 160 | 3 | 12432077 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 5.08e-05 | 281 | 160 | 8 | 28706196 | |
| Pubmed | Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. | 5.12e-05 | 16 | 160 | 3 | 16096065 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH10 POLR1A MYO5A MYCBP2 ACLY SPTBN1 WDR70 ADNP2 ARID1A COMMD3 POLR3A PLEK2 SMG8 RPL7L1 MACF1 AGRN TP53BP1 SLC27A4 | 5.49e-05 | 1353 | 160 | 18 | 29467282 |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 11294830 | ||
| Pubmed | The molecular circuitry regulating the switch between iron deficiency and overload in mice. | 6.29e-05 | 3 | 160 | 2 | 16418170 | |
| Pubmed | Dynamic regulation of CD45 lateral mobility by the spectrin-ankyrin cytoskeleton of T cells. | 6.29e-05 | 3 | 160 | 2 | 20164196 | |
| Pubmed | Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma. | 6.29e-05 | 3 | 160 | 2 | 21599592 | |
| Pubmed | HLA associations and HLA sharing in recurrent miscarriage: A systematic review and meta-analysis. | 6.29e-05 | 3 | 160 | 2 | 25700963 | |
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 6.29e-05 | 3 | 160 | 2 | 16079285 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 28209919 | ||
| Pubmed | CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia. | 6.29e-05 | 3 | 160 | 2 | 25316523 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 19428458 | ||
| Pubmed | β spectrin-dependent and domain specific mechanisms for Na+ channel clustering. | 6.29e-05 | 3 | 160 | 2 | 32425157 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 36344675 | ||
| Pubmed | [Analysis on HLA-E polymorphism in Guangdong Han population]. | 6.29e-05 | 3 | 160 | 2 | 15631661 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 10878022 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 18059271 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 12408964 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 34818527 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 11973331 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 17462627 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 34183176 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 8479293 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 33472039 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 25850813 | ||
| Pubmed | Developmental expression of brain beta-spectrin isoform messenger RNAs. | 6.29e-05 | 3 | 160 | 2 | 1467942 | |
| Pubmed | Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. | 6.29e-05 | 3 | 160 | 2 | 25516977 | |
| Pubmed | 6.39e-05 | 147 | 160 | 6 | 16959763 | ||
| Pubmed | ARHGAP32 MYH10 SLC4A7 TRIO MYO5A MYCBP2 CAMK2B PCLO SPTBN1 TACC2 ADD3 NEO1 DOCK7 MAP3K10 MACF1 TP53BP1 | 7.77e-05 | 1139 | 160 | 16 | 36417873 | |
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 8.88e-05 | 156 | 160 | 6 | 30409884 | |
| Pubmed | 1.03e-04 | 20 | 160 | 3 | 18723693 | ||
| Pubmed | 1.08e-04 | 233 | 160 | 7 | 29518331 | ||
| Pubmed | MKRN2 OSR2 TACC2 ARID1A ZNF692 ZBTB14 ZNF462 ZBTB49 OVOL1 MRPS17 MACF1 MYBL2 | 1.16e-04 | 709 | 160 | 12 | 22988430 | |
| Pubmed | Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120. | 1.20e-04 | 21 | 160 | 3 | 7539755 | |
| Pubmed | BLM helicase regulates DNA repair by counteracting RAD51 loading at DNA double-strand break sites. | 1.25e-04 | 4 | 160 | 2 | 28912125 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 19586902 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 16648470 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 25421756 | ||
| Pubmed | Viral induction of Zac1b through TLR3- and IRF3-dependent pathways. | 1.25e-04 | 4 | 160 | 2 | 20947170 | |
| Pubmed | Myosin X regulates netrin receptors and functions in axonal path-finding. | 1.25e-04 | 4 | 160 | 2 | 17237772 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 31259687 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 29520062 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 11210191 | ||
| Pubmed | Outer nuclear membrane protein Kuduk modulates the LINC complex and nuclear envelope architecture. | 1.25e-04 | 4 | 160 | 2 | 28716842 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 21419663 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 21521693 | ||
| Pubmed | Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. | 1.25e-04 | 4 | 160 | 2 | 16148088 | |
| Pubmed | LINC complexes mediate the positioning of cone photoreceptor nuclei in mouse retina. | 1.25e-04 | 4 | 160 | 2 | 23071752 | |
| Pubmed | Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells. | 1.25e-04 | 4 | 160 | 2 | 25754738 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 1.25e-04 | 4 | 160 | 2 | 3862089 | |
| Pubmed | STEF/TIAM2-mediated Rac1 activity at the nuclear envelope regulates the perinuclear actin cap. | 1.25e-04 | 4 | 160 | 2 | 29844364 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 21412925 | ||
| Pubmed | Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development. | 1.25e-04 | 4 | 160 | 2 | 20108321 | |
| Interaction | TNIK interactions | ARHGAP32 TRIO MYO5A MYCBP2 CAMK2B SYNE1 SPTBN1 RPS27 DNAJC2 ZNF462 SYNE2 DOCK7 MACF1 AGRN TP53BP1 | 3.39e-07 | 381 | 158 | 15 | int:TNIK |
| Cytoband | 3p14.1 | 8.12e-05 | 24 | 161 | 3 | 3p14.1 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF474 ADNP2 OSR2 ZKSCAN2 ZNF692 ZNF768 ZBTB14 ZNF462 ZBTB49 ZSCAN32 OVOL1 ZSCAN1 ZNF335 PLAGL1 ZNF572 | 2.63e-05 | 718 | 109 | 15 | 28 |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 9.20e-05 | 15 | 109 | 3 | 903 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 2.14e-04 | 4 | 109 | 2 | 1252 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 5.01e-04 | 26 | 109 | 3 | 904 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.76e-04 | 66 | 109 | 4 | 722 | |
| GeneFamily | EF-hand domain containing|Spectrins | 7.42e-04 | 7 | 109 | 2 | 1113 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.56e-03 | 206 | 109 | 6 | 682 | |
| GeneFamily | PDZ domain containing | 2.28e-03 | 152 | 109 | 5 | 1220 | |
| GeneFamily | Rhomboid family | 3.13e-03 | 14 | 109 | 2 | 926 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 3.21e-03 | 49 | 109 | 3 | 584 | |
| GeneFamily | AT-rich interaction domain containing | 3.59e-03 | 15 | 109 | 2 | 418 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.01e-03 | 53 | 109 | 3 | 532 | |
| Coexpression | GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN | 1.56e-06 | 179 | 159 | 9 | M5664 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP | 3.88e-06 | 200 | 159 | 9 | M4379 | |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 4.30e-06 | 152 | 159 | 8 | M39239 | |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 1.55e-05 | 181 | 159 | 8 | M39225 | |
| Coexpression | GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 2.64e-05 | 195 | 159 | 8 | M5328 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP | 3.17e-05 | 200 | 159 | 8 | M5192 | |
| Coexpression | GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 3.17e-05 | 200 | 159 | 8 | M6975 | |
| Coexpression | GSE6674_UNSTIM_VS_CPG_STIM_BCELL_UP | 3.31e-05 | 147 | 159 | 7 | M6918 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | THEMIS HLA-B MYO5A MYCBP2 DOCK8 SYNE1 HLA-E RPS27 JADE1 ARID1A PTPRC ST3GAL5 CD101 SYNE2 MACF1 PREX1 FMNL1 | 4.11e-05 | 911 | 159 | 17 | M40038 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | TRIO SPTBN1 BCORL1 ASH1L OSR2 ABCC5 FRMD4B SVEP1 ADD3 ZNF462 IGFBP5 ADAMTS9 STARD9 NRK SYNE2 ARID5B EEF2K MYOCD | 1.77e-05 | 790 | 154 | 18 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | TRIO SPTBN1 BCORL1 ASH1L OSR2 CPED1 FRMD4B TRIM23 ADD3 ZNF462 FNDC1 ADAMTS9 STARD9 NRK SYNE2 ARID5B EEF2K MYOCD | 2.06e-05 | 799 | 154 | 18 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 2.92e-05 | 166 | 154 | 8 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | SPTBN1 BCORL1 ASH1L OSR2 FRMD4B ADD3 ADAMTS9 STARD9 NRK SYNE2 ARID5B MYOCD | 4.03e-05 | 404 | 154 | 12 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | MYH10 NET1 OSR2 CPED1 FRMD4B SVEP1 DACT1 NKD1 IGFBP5 NRK MYRF | 5.69e-05 | 354 | 154 | 11 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | POLR1A TRIO SPTBN1 BCORL1 ASH1L OSR2 FRMD4B SVEP1 TRIM23 ADD3 ZNF462 NKD1 ADAMTS9 STARD9 NRK SYNE2 ARID5B | 7.40e-05 | 801 | 154 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100 | 1.04e-04 | 34 | 154 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | MAGI1 MYH10 NET1 CALU CPED1 FRMD4B SVEP1 ZNF462 DACT1 NEO1 NKD1 IGFBP5 ADAMTS9 NRK SYNE2 PLAGL1 MYRF | 1.09e-04 | 827 | 154 | 17 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | MYH10 SLC4A7 MYO5A ACLY VPS50 ARID1A CHN1 DNAJC2 PLEK2 ZNF462 CLIC5 SETBP1 SYNE2 POC1B KIAA1328 DOCK7 MACF1 FAM149B1 XKR5 TP53BP1 SLC27A4 MYBL2 | 1.10e-04 | 1257 | 154 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 1.24e-04 | 152 | 154 | 7 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.38e-04 | 207 | 154 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | SPTBN1 BCORL1 ASH1L OSR2 ADD3 FNDC1 ADAMTS9 NRK SYNE2 ARID5B MYOCD | 1.50e-04 | 395 | 154 | 11 | gudmap_developingGonad_P2_epididymis_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.81e-04 | 337 | 154 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | SLC4A7 FMO5 HLA-B DOCK8 ASAH2 SYNE1 SPTBN1 HLA-E LRRK2 CHN1 CPED1 ARHGEF15 IGFBP5 SBF2 SETBP1 ARID5B DOCK6 | 2.04e-04 | 872 | 154 | 17 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | POLR1A SPTBN1 BCORL1 ASH1L OSR2 CPED1 FRMD4B ADD3 FNDC1 ADAMTS9 STARD9 NRK SYNE2 ARID5B EEF2K MYOCD | 2.29e-04 | 797 | 154 | 16 | gudmap_developingGonad_P2_epididymis_1000 |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | MPP3 MAGI1 NRG1 SPTBN1 MAGI3 TACC2 PTPN21 CLIC5 RP1 MYRF FYB2 | 7.75e-11 | 184 | 161 | 11 | 561592edc3083fad41b91811151b442207c65dd9 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | MPP3 MAGI1 NRG1 SPTBN1 MAGI3 PTPN21 CLIC5 COBL RP1 MYRF FYB2 | 8.21e-11 | 185 | 161 | 11 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 8.46e-10 | 174 | 161 | 10 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 1.62e-09 | 186 | 161 | 10 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-09 | 187 | 161 | 10 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-09 | 190 | 161 | 10 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.68e-09 | 196 | 161 | 10 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.68e-09 | 196 | 161 | 10 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | MYH10 SLC4A7 SYNE1 TACC2 CPED1 DACT1 FNDC1 IGFBP5 ARID5B MYOCD | 3.26e-09 | 200 | 161 | 10 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.24e-08 | 170 | 161 | 9 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-08 | 186 | 161 | 9 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.83e-08 | 187 | 161 | 9 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 3.10e-08 | 189 | 161 | 9 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-08 | 195 | 161 | 9 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.24e-08 | 196 | 161 | 9 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.43e-08 | 197 | 161 | 9 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-CD4+_CTL|ICU-NoSEP / Disease, condition lineage and cell class | 5.04e-08 | 200 | 161 | 9 | c470520ce77130811fdc2a1d3d796d8836275de1 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.93e-07 | 169 | 161 | 8 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-07 | 172 | 161 | 8 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-07 | 172 | 161 | 8 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.70e-07 | 184 | 161 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-07 | 184 | 161 | 8 | 5b4f18b26d03e8e5798cac70d124534749fc4cc0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.70e-07 | 184 | 161 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_TEM|Control / Disease, Lineage and Cell Type | 4.18e-07 | 187 | 161 | 8 | 7fdff970a9397305d0b8194c00a043cc69dcca12 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.72e-07 | 190 | 161 | 8 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8|bone_marrow / Manually curated celltypes from each tissue | 4.72e-07 | 190 | 161 | 8 | be281c7c717c11ef3c5cbccd22628acf1bd9727f | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.11e-07 | 192 | 161 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.11e-07 | 192 | 161 | 8 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.31e-07 | 193 | 161 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD8_TEM|ICU-NoSEP / Disease, Lineage and Cell Type | 5.31e-07 | 193 | 161 | 8 | 848d47d3b1035f0fb36911d71d48976ee9d013fc | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.53e-07 | 194 | 161 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-07 | 194 | 161 | 8 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 5.74e-07 | 195 | 161 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 5.74e-07 | 195 | 161 | 8 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 5.74e-07 | 195 | 161 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 5.74e-07 | 195 | 161 | 8 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | COVID-19-Lymphoid-CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | 5.74e-07 | 195 | 161 | 8 | d4c70a462b98963e78f4e2659574bc350f8ffe1a | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 5.97e-07 | 196 | 161 | 8 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.97e-07 | 196 | 161 | 8 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.97e-07 | 196 | 161 | 8 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.97e-07 | 196 | 161 | 8 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.20e-07 | 197 | 161 | 8 | f73ece3aca28c0db5db0f12e026d42c6c36b9efb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.20e-07 | 197 | 161 | 8 | e70e7d97823a762def3970d94a0e897981a6c922 | |
| ToppCell | normal_Lung-T/NK_cells-CD8_low_T|normal_Lung / Location, Cell class and cell subclass | 6.20e-07 | 197 | 161 | 8 | 559b22ff973a1551e614a972085343e7d8e8a668 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.20e-07 | 197 | 161 | 8 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.20e-07 | 197 | 161 | 8 | 2b3a56bb1d40bc1284a5931c4e7b373660de5402 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_Tem|COVID-19_Severe / Disease group, lineage and cell class | 6.20e-07 | 197 | 161 | 8 | f0bac4d5c3160933ac3786cec8dadffb35d711ea | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8-Tem/emra_CD8|Lung / Manually curated celltypes from each tissue | 6.20e-07 | 197 | 161 | 8 | a573a59e2271f5d0ce5de0b851951ab72659e060 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8|Lung / Manually curated celltypes from each tissue | 6.20e-07 | 197 | 161 | 8 | b2f5b35e931c1342e541ecf05933350c41612415 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.20e-07 | 197 | 161 | 8 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-07 | 197 | 161 | 8 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 | |
| ToppCell | background-Kupffer_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 6.20e-07 | 197 | 161 | 8 | 8b45c7ecc18d188abc8c172d9bf881c95617a46a | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.20e-07 | 197 | 161 | 8 | bce0135a96910d2bace62a3408a1a6fdac0cf0df | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.20e-07 | 197 | 161 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.20e-07 | 197 | 161 | 8 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 6.22e-07 | 135 | 161 | 7 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-07 | 198 | 161 | 8 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-07 | 198 | 161 | 8 | 440af8f90c7afa1c07000806bcf9110b70f489fb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-07 | 198 | 161 | 8 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-07 | 198 | 161 | 8 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-07 | 198 | 161 | 8 | 451003a21162eeae90739fdb502bb50b362d80c8 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.45e-07 | 198 | 161 | 8 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 6.70e-07 | 199 | 161 | 8 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.70e-07 | 199 | 161 | 8 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-CD8+_Tem|ICU-NoSEP / Disease, condition lineage and cell class | 6.95e-07 | 200 | 161 | 8 | c02584afc76216dd8b9985fa27c5cf93712f5745 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_Tem|COVID-19_Severe / Disease, condition lineage and cell class | 6.95e-07 | 200 | 161 | 8 | 31859b8db7ea17e48b7b54e92f0d76aeb755e7ca | |
| ToppCell | severe-CD8+_Tem|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.95e-07 | 200 | 161 | 8 | aaa2cd326dc15dee2fd975ca133359c5826f6a75 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 6.95e-07 | 200 | 161 | 8 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.94e-07 | 140 | 161 | 7 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 1.71e-06 | 157 | 161 | 7 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-06 | 162 | 161 | 7 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 2.20e-06 | 163 | 161 | 7 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 171 | 161 | 7 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.02e-06 | 171 | 161 | 7 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-06 | 171 | 161 | 7 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.26e-06 | 173 | 161 | 7 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-06 | 173 | 161 | 7 | b06d6e7acb7086bb99600b680cf404c0ef06b52c | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.39e-06 | 174 | 161 | 7 | 4a1b67ce5ea353b3f81f59fa57da07668146afca | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 175 | 161 | 7 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.79e-06 | 177 | 161 | 7 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.08e-06 | 179 | 161 | 7 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 4.08e-06 | 179 | 161 | 7 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 180 | 161 | 7 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.24e-06 | 180 | 161 | 7 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 180 | 161 | 7 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 4.72e-06 | 183 | 161 | 7 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-06 | 183 | 161 | 7 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 4.72e-06 | 183 | 161 | 7 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-06 | 183 | 161 | 7 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.72e-06 | 183 | 161 | 7 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 5.07e-06 | 185 | 161 | 7 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 5.07e-06 | 185 | 161 | 7 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.07e-06 | 185 | 161 | 7 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.07e-06 | 185 | 161 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | mild_COVID-19-CD4+_CTL|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.44e-06 | 187 | 161 | 7 | 49196d07e4716c87d33229a4569bdb6b4613b3eb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.44e-06 | 187 | 161 | 7 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.64e-06 | 188 | 161 | 7 | 0ddc5dbe2fd905fee20c33d9845629e259faacd9 | |
| Disease | testosterone measurement | MAGI1 POLR1A MYO5A BCORL1 UGT2A2 PTPN21 ARID1A ARHGEF15 DACT1 OVOL1 ST3GAL5 SBF2 SYNE2 SEC23IP ARID5B UGT2B17 MACF1 PLAGL1 MYOCD JPT2 JHY | 3.94e-06 | 1275 | 156 | 21 | EFO_0004908 |
| Disease | Intellectual Disability | TRIO DOCK8 CAMK2B SYNE1 APC2 ASH1L ZNF462 ST3GAL5 ZNF335 SETBP1 MACF1 TET3 | 4.97e-06 | 447 | 156 | 12 | C3714756 |
| Disease | platelet component distribution width | MPP3 SLC4A7 HLA-B DOCK8 SYNE1 LRRK2 ABCC5 SVEP1 ARHGEF15 PTPRC CLIC5 SYNJ2 DOCK7 MACF1 PREX1 | 1.23e-05 | 755 | 156 | 15 | EFO_0007984 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.53e-05 | 222 | 156 | 8 | EFO_0008317, EFO_0020943 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.69e-05 | 224 | 156 | 8 | EFO_0004530, EFO_0008317 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 3.99e-05 | 13 | 156 | 3 | OBA_2045159 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 4.01e-05 | 118 | 156 | 6 | EFO_0010119 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 4.65e-05 | 74 | 156 | 5 | EFO_0022280 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 4.86e-05 | 315 | 156 | 9 | EFO_0004612, EFO_0008591 | |
| Disease | docosahexaenoic acid measurement | 6.05e-05 | 127 | 156 | 6 | EFO_0007761 | |
| Disease | cholesteryl ester measurement | 7.10e-05 | 257 | 156 | 8 | EFO_0010351 | |
| Disease | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 8.30e-05 | 3 | 156 | 2 | C1292772 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 8.56e-05 | 264 | 156 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | hair colour measurement | DNAJB12 NRG1 MSL1 ARID1A ADD3 NEO1 OVOL1 CLIC5 SBF2 SETBP1 SYNE2 POC1B | 1.11e-04 | 615 | 156 | 12 | EFO_0007822 |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 1.12e-04 | 18 | 156 | 3 | OBA_2045155 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.16e-04 | 276 | 156 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | glycerophospholipid measurement | 1.32e-04 | 49 | 156 | 4 | EFO_0007630 | |
| Disease | neutrophil count | MAGI1 HLA-B MYCBP2 DOCK8 SPTBN1 BCORL1 ASH1L ABCC5 MAGI3 ARID1A PTPRC CSF3R CD101 SBF2 PLAGL1 RP1 DOCK6 MYRF PREX1 | 1.34e-04 | 1382 | 156 | 19 | EFO_0004833 |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.65e-04 | 4 | 156 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | lactosyl-N-behenoyl-sphingosine (d18:1/22:0) measurement | 1.65e-04 | 4 | 156 | 2 | EFO_0800518 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.65e-04 | 4 | 156 | 2 | cv:CN293514 | |
| Disease | occupational asthma (is_implicated_in) | 1.65e-04 | 4 | 156 | 2 | DOID:0080820 (is_implicated_in) | |
| Disease | Sotos' syndrome | 1.65e-04 | 4 | 156 | 2 | C0175695 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.67e-04 | 291 | 156 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | Malignant neoplasm of breast | NRG1 NET1 SYNE1 APC2 BCORL1 TACC2 ARID1A PPARGC1B NSUN6 PTPRC IGFBP5 SYNJ2 SETBP1 SYNE2 MACF1 TP53BP1 | 1.92e-04 | 1074 | 156 | 16 | C0006142 |
| Disease | triglycerides in medium VLDL measurement | 2.08e-04 | 55 | 156 | 4 | EFO_0022155 | |
| Disease | phospholipids:total lipids ratio | 2.15e-04 | 227 | 156 | 7 | EFO_0020946 | |
| Disease | triglycerides in large VLDL measurement | 2.23e-04 | 56 | 156 | 4 | EFO_0022178 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 2.38e-04 | 23 | 156 | 3 | OBA_2045158 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 2.75e-04 | 5 | 156 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 2.75e-04 | 5 | 156 | 2 | C0410190 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 2.86e-04 | 315 | 156 | 8 | EFO_0004574, EFO_0004612 | |
| Disease | total lipids in VLDL measurement | 2.91e-04 | 60 | 156 | 4 | EFO_0022314 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.93e-04 | 239 | 156 | 7 | EFO_0008317, EFO_0020945 | |
| Disease | eosinophil count | IP6K3 HLA-B SPTBN1 MKRN2 SLC35E1 ABCC5 ZKSCAN2 SVEP1 ADD3 FNDC1 PTPRC CLIC5 NKD1 SBF2 POC1B PLAGL1 MYRF TET3 TP53BP1 | 3.40e-04 | 1488 | 156 | 19 | EFO_0004842 |
| Disease | unipolar depression, depressive symptom measurement | 3.45e-04 | 26 | 156 | 3 | EFO_0003761, EFO_0007006 | |
| Disease | mean platelet volume | MPP3 ARHGAP32 HLA-B MYO5A DOCK8 SPTBN1 BCORL1 LRRK2 ABCC5 SVEP1 PTPRC ST3GAL5 SETBP1 SYNE2 DOCK7 | 3.50e-04 | 1020 | 156 | 15 | EFO_0004584 |
| Disease | triglycerides to total lipids in medium VLDL percentage | 3.51e-04 | 63 | 156 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 3.51e-04 | 63 | 156 | 4 | EFO_0022239 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 3.89e-04 | 330 | 156 | 8 | EFO_0004529, EFO_0004612 | |
| Disease | cholesterol in very large VLDL measurement | 3.96e-04 | 65 | 156 | 4 | EFO_0022230 | |
| Disease | Emery-Dreifuss muscular dystrophy | 4.11e-04 | 6 | 156 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 4.11e-04 | 6 | 156 | 2 | C0410189 | |
| Disease | total lipids in large VLDL | 4.45e-04 | 67 | 156 | 4 | EFO_0022175 | |
| Disease | monocyte percentage of leukocytes | POLR1A HLA-B DOCK8 MKRN2 ABCC5 ARID1A PTPRC CSF3R ST3GAL5 POC1B KIAA1755 PLAGL1 | 5.35e-04 | 731 | 156 | 12 | EFO_0007989 |
| Disease | neuroimaging measurement | MAGI1 MYH10 ZNF474 SPTBN1 TACC2 RPS27 PTPN21 METTL4 SLC40A1 FRMD4B ZNF462 DACT1 NEO1 KIAA1755 MACF1 | 5.70e-04 | 1069 | 156 | 15 | EFO_0004346 |
| Disease | uveal melanoma disease severity | 5.73e-04 | 7 | 156 | 2 | EFO_0010244 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 5.73e-04 | 7 | 156 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 5.73e-04 | 7 | 156 | 2 | C0751337 | |
| Disease | Breast Carcinoma | NRG1 SYNE1 APC2 ARID1A PPARGC1B NSUN6 IGFBP5 SYNJ2 SETBP1 TP53BP1 | 6.10e-04 | 538 | 156 | 10 | C0678222 |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 6.83e-04 | 75 | 156 | 4 | EFO_0007006, EFO_0009262 | |
| Disease | Autistic behavior | 7.62e-04 | 8 | 156 | 2 | C0856975 | |
| Disease | hypothyroidism | 8.17e-04 | 284 | 156 | 7 | EFO_0004705 | |
| Disease | cortical thickness | MAGI1 ZNF474 HLA-B MYCBP2 SPTBN1 TACC2 CPED1 FRMD4B ZNF462 DACT1 NEO1 ADAMTS9 DOCK7 KIAA1755 MACF1 | 8.59e-04 | 1113 | 156 | 15 | EFO_0004840 |
| Disease | alcohol consumption measurement | MPP3 MAGI1 MYH10 HLA-B CALU PCLO SPTBN1 MAGI3 BRMS1L JADE1 DACT1 SETBP1 ARID5B COBL TET3 AGRN | 9.29e-04 | 1242 | 156 | 16 | EFO_0007878 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.03e-03 | 144 | 156 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.14e-03 | 86 | 156 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | bone quantitative ultrasound measurement | 1.15e-03 | 39 | 156 | 3 | EFO_0004514 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.24e-03 | 150 | 156 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | PR interval | MAGI1 MYCBP2 SPTBN1 METTL4 FRMD4B SYNE2 KIAA1755 MACF1 MYOCD | 1.33e-03 | 495 | 156 | 9 | EFO_0004462 |
| Disease | Paroxysmal atrial fibrillation | 1.47e-03 | 156 | 156 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.47e-03 | 156 | 156 | 5 | C3468561 | |
| Disease | unipolar depression, bipolar disorder | 1.47e-03 | 156 | 156 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Persistent atrial fibrillation | 1.47e-03 | 156 | 156 | 5 | C2585653 | |
| Disease | peanut allergy measurement, parental genotype effect measurement | 1.48e-03 | 11 | 156 | 2 | EFO_0005939, EFO_0007017 | |
| Disease | Neurodevelopmental Disorders | 1.52e-03 | 93 | 156 | 4 | C1535926 | |
| Disease | triglycerides in large LDL measurement | 1.53e-03 | 43 | 156 | 3 | EFO_0022319 | |
| Disease | Atrial Fibrillation | 1.65e-03 | 160 | 156 | 5 | C0004238 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.65e-03 | 321 | 156 | 7 | EFO_0004612, EFO_0004639 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.77e-03 | 12 | 156 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | triglyceride measurement, alcohol drinking | 1.92e-03 | 99 | 156 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | Mammary Carcinoma, Human | 1.98e-03 | 525 | 156 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.98e-03 | 525 | 156 | 9 | C1257931 | |
| Disease | Adenoid Cystic Carcinoma | 1.99e-03 | 100 | 156 | 4 | C0010606 | |
| Disease | Mammary Neoplasms | 2.03e-03 | 527 | 156 | 9 | C1458155 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.06e-03 | 101 | 156 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | Vitiligo | 2.06e-03 | 101 | 156 | 4 | EFO_0004208 | |
| Disease | velocity of sound measurement | 2.08e-03 | 13 | 156 | 2 | EFO_0005654 | |
| Disease | obsolete_red blood cell distribution width | MPP3 POLR1A DOCK8 ASAH2 SPTB MKRN2 ABCC5 SLC40A1 NEO1 ST3GAL5 SYNE2 NFRKB LRRC14 RP1 DOCK6 MYBL2 | 2.13e-03 | 1347 | 156 | 16 | EFO_0005192 |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.21e-03 | 103 | 156 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | fatty acid measurement | 2.31e-03 | 436 | 156 | 8 | EFO_0005110 | |
| Disease | omega-6:omega-3 polyunsaturated fatty acid ratio | 2.37e-03 | 50 | 156 | 3 | EFO_0010732 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 2.37e-03 | 50 | 156 | 3 | EFO_0022247 | |
| Disease | lipoprotein measurement | 2.38e-03 | 105 | 156 | 4 | EFO_0004732 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 2.51e-03 | 51 | 156 | 3 | EFO_0022302 | |
| Disease | brain measurement, neuroimaging measurement | 2.71e-03 | 550 | 156 | 9 | EFO_0004346, EFO_0004464 | |
| Disease | liver volume | 2.79e-03 | 15 | 156 | 2 | EFO_0600048 | |
| Disease | unipolar depression, cognitive function measurement | 2.79e-03 | 15 | 156 | 2 | EFO_0003761, EFO_0008354 | |
| Disease | bone fracture | 3.00e-03 | 112 | 156 | 4 | EFO_0003931 | |
| Disease | cardiovascular disease | 3.08e-03 | 457 | 156 | 8 | EFO_0000319 | |
| Disease | hepcidin:ferritin ratio | 3.11e-03 | 55 | 156 | 3 | EFO_0007901 | |
| Disease | linoleic acid measurement | 3.16e-03 | 186 | 156 | 5 | EFO_0006807 | |
| Disease | triglycerides in LDL measurement | 3.27e-03 | 56 | 156 | 3 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 3.27e-03 | 56 | 156 | 3 | EFO_0022325 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 3.44e-03 | 57 | 156 | 3 | EFO_0022284 | |
| Disease | Cannabis Dependence | 3.59e-03 | 17 | 156 | 2 | C0006870 | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 3.59e-03 | 17 | 156 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | adult onset asthma | 3.62e-03 | 118 | 156 | 4 | EFO_1002011 | |
| Disease | triglycerides in VLDL measurement | 3.79e-03 | 59 | 156 | 3 | EFO_0022326 | |
| Disease | phospholipids in VLDL measurement | 3.79e-03 | 59 | 156 | 3 | EFO_0022301 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EHLVLKSASPHKDLP | 891 | Q9BXT4 | |
| KKRRHSFEHVSLIPP | 1221 | Q9NR48 | |
| PHLELNPDFHPKIKD | 581 | A4D0V7 | |
| HPLIREKPRHKSDVE | 391 | Q9UEY8 | |
| KPKRSHRKADPDAAH | 321 | Q6P6C2 | |
| KAPVSHHFLEPPKIR | 181 | A6NHR8 | |
| GRHPLHLLEDAVTKP | 2046 | O00468 | |
| LLPHDSHPKELILDV | 1011 | Q5H9F3 | |
| LLHKPKPLREVAPDH | 26 | Q3C1V8 | |
| PTEKKDRVHHEPQLS | 21 | O43852 | |
| SLESRAAPKHLHKTP | 776 | O94989 | |
| AIHKLHLPEPLERFL | 306 | Q8WXH4 | |
| LKHHPDKRKAAGEPI | 116 | Q99543 | |
| KRKPADLHNLAPGTH | 216 | Q9NZA1 | |
| LKQTHIAPKPAAHLA | 261 | Q6IQ32 | |
| LHPFDPEQRKAHEKI | 201 | Q9H000 | |
| LPSLAPLGHKKHKHR | 391 | Q969G9 | |
| KEGKHHLRVRPADLP | 106 | Q17RG1 | |
| VTPPRLREKKFDHHP | 481 | Q02297 | |
| LLKEILKHTPKEHPD | 321 | Q7Z628 | |
| LKHTPKEHPDVQLLE | 326 | Q7Z628 | |
| LLHHKHPERKQAPLT | 2016 | O14497 | |
| GKETLLHLEPPKTHV | 196 | P13747 | |
| HRKPSFLALPGHLVK | 26 | P43632 | |
| HNDAPVPIIHRDLKS | 211 | Q02779 | |
| KSSPHGEKRAHARDP | 1281 | Q96QZ7 | |
| KPASQHSEEHLDKIP | 1226 | Q5TCQ9 | |
| HSEEHLDKIPSPLKN | 1231 | Q5TCQ9 | |
| THPPLKKEDLHRISK | 26 | Q6NUN7 | |
| EKRKHQPDHPDLLTG | 266 | Q6P4R8 | |
| KELLHSVHPESPNLK | 551 | Q9Y217 | |
| ISPEDHSKKRDPHTI | 676 | A4FU01 | |
| HSKKRDPHTILNPTE | 681 | A4FU01 | |
| DNHAPHLKQKDKLPD | 691 | Q86WG5 | |
| HLDRDPEKLTHHMPL | 531 | P59045 | |
| GSHKLPDPAREHLLA | 1141 | Q5JYT7 | |
| LHPFRKVRVHPEKSL | 721 | A6NM62 | |
| KECHKPKPILLHTGE | 496 | Q9NR71 | |
| ATSRLAHPNKPKDHV | 101 | Q9H910 | |
| HLELHEPPKAVDKAK | 4601 | Q9Y6V0 | |
| HLSHNKLKEIPPEIG | 1251 | Q5S007 | |
| LPRQDEEKPLHALLH | 81 | P24593 | |
| KEAERHHSSPKRELP | 251 | Q96N16 | |
| KRNLKRLHFDSPPHL | 311 | Q8TC44 | |
| VSDHLAHREPKSQKP | 346 | Q2M2Z5 | |
| AEAHFLPRHRKLKEP | 41 | Q68DK7 | |
| ERKFETLLKHLSHPP | 36 | Q8TEA1 | |
| AIAHVLPALHKDRPR | 101 | Q8N2R0 | |
| VDKLHHPLEFADKSP | 1221 | A7KAX9 | |
| PKPERSHSLKLHHTQ | 1981 | A7KAX9 | |
| PSLVKRQKTHFHDLP | 176 | Q13868 | |
| DKLERADPPKTHVTH | 201 | P01889 | |
| KESPAKALLRSEPHL | 136 | Q96PC2 | |
| SLKPVTLHHPKDDLD | 246 | Q86T90 | |
| TLHHPKDDLDKIPSE | 251 | Q86T90 | |
| PLKRPAEFHEQRKHL | 41 | Q8IZQ8 | |
| AEHKPHIDKLLKIGP | 5831 | Q9UPN3 | |
| HLKEHHPDSPLLRKT | 231 | O14753 | |
| HILEPKAHVPDAEKR | 756 | Q16825 | |
| HSQLRILDEEHPKGK | 66 | O15440 | |
| LDHPDLKHIDPVVLK | 46 | Q9UBI1 | |
| LDHRVLDHDLPKKPG | 116 | Q9Y2L6 | |
| LPADHLSKVPEKLAA | 1031 | O95996 | |
| PSHLCHTDLKPEERK | 1711 | Q9P2N4 | |
| KQSPDSHVHLRKPAA | 396 | Q93033 | |
| LEAAGEPALRKKAHH | 136 | P0C671 | |
| HLPKTAKPASQEHAR | 451 | Q9NYF0 | |
| EIPEDPKLFRHHNKL | 1956 | Q96HP0 | |
| SEIPSDPKLFRHHNK | 2046 | Q96N67 | |
| APRPASKKHFHEELA | 951 | Q8NF50 | |
| ASDNHLKKPKHRDPE | 346 | Q14241 | |
| HVHPKGPKSLLSLEL | 216 | P15391 | |
| SVDHPLKPRHVKLLS | 36 | Q4ZHG4 | |
| GLKPKHRALSQHPTL | 271 | P49326 | |
| RRLALKFHPDKNHAP | 131 | Q9NXW2 | |
| EKAREEVPALHPASH | 591 | O75128 | |
| DTHRLHKEGKLLPLV | 136 | Q9NS18 | |
| RERKHHLKHGPNAPS | 101 | Q9NTQ9 | |
| APSHAPELHLKHIGK | 526 | Q99062 | |
| VPKSRHLTIKLTPAH | 196 | O95466 | |
| RLALKHHPLKSNEPS | 26 | P59910 | |
| TEPPVKLEKHLHSAR | 241 | Q5PSV4 | |
| ELKDRPGKPLFHLEH | 216 | O00418 | |
| LETLHEALKLLPPAH | 376 | P15882 | |
| PKIRLKPHRLGDSEH | 331 | Q6NUJ5 | |
| EEKKPDPLHQLVLHF | 3691 | P21817 | |
| HIRKAKASDLPPLEH | 261 | Q8NEC7 | |
| LHSHKPPLAEVLKDY | 416 | Q8N3J2 | |
| PNHEKRAGKLDPHLV | 681 | P35580 | |
| DKGLHISHNPLSKPL | 266 | A6NM36 | |
| ASLKKPDFPEAIAHH | 896 | P56715 | |
| KHALNHHPPPEKLEE | 21 | Q96BN6 | |
| RLAEDRSKDPHDPHK | 91 | Q14653 | |
| AVPHTTRPRKSHEKE | 416 | Q13368 | |
| HEGEKLSLPRHLKVV | 151 | Q9NQ35 | |
| HLLKLKVFPTLDHKP | 1396 | Q7Z2Y5 | |
| PKKHSPKRRLQHALE | 291 | Q8ND04 | |
| NPAKRITAHEALKHP | 256 | Q13554 | |
| LDHLKAHAEEKPPSG | 136 | Q9UM63 | |
| QHLHEVLSRADPKKA | 1051 | O95602 | |
| DIGKKHSDPHLLERN | 236 | Q9Y6M7 | |
| YHKKLIRLPLPDDEH | 8206 | Q8NF91 | |
| KAHVTDPKADPRALL | 6686 | Q8WXH0 | |
| ASAAKAELPPDHEHK | 1456 | O15056 | |
| LEVKPHALELPDKHS | 81 | Q6DKI1 | |
| DPHKREVLLALADSH | 71 | P58872 | |
| ESEHHPSPDSIKRRK | 166 | Q8WWF3 | |
| TTPLHRDKTPLHQKH | 486 | P10244 | |
| APEKQPDVRHHHLPK | 251 | Q5VWT5 | |
| HHERLELKPIDKSPD | 1166 | Q92859 | |
| LKELAKRTPGKHPDH | 206 | Q8TCU6 | |
| AHKLPKKHPERSELL | 651 | Q86YN6 | |
| RSLPHFEKHSKLPAA | 816 | O14802 | |
| ELLPEHDLPEHLKAK | 176 | Q9UNP4 | |
| LHKDTEPKPLEGTHL | 251 | Q9NP59 | |
| KFHPELSKEHAPIRS | 3056 | O75592 | |
| KHLPHAFSKLENPRR | 266 | Q14191 | |
| LRALPVPRAKHVKHE | 66 | Q9Y2R5 | |
| VPDLDLKAVLIPHHK | 836 | Q9Y6Y8 | |
| DLGKEPFKAAPHTIH | 2981 | Q9P2P6 | |
| PKHSSHRKPEESLGK | 366 | Q6IE81 | |
| SLVHSLKKPHKRDPL | 586 | Q6IE81 | |
| SSKERHRSPLEKPHN | 356 | Q96K37 | |
| PPASLGHIKKRHEIS | 1176 | Q4LDE5 | |
| LVHSHELPLDPAKLD | 96 | O75783 | |
| LIHKHRPDLIDFDKL | 211 | Q01082 | |
| NPEDIKKHLLVHAPE | 161 | P53396 | |
| HLKESHLPKLITPAE | 156 | Q5VW32 | |
| HHPEDVEPALRKTLA | 86 | P14550 | |
| DKLLEKRALPHSHMP | 811 | Q14865 | |
| HPLSLSHKPAKKIDV | 126 | Q96AQ7 | |
| HRKIHVEKPFESPDV | 486 | Q7Z3I7 | |
| ERTVDLPKSPKRHHV | 576 | Q8N1K5 | |
| ERKEKVPSPHLSHLV | 701 | Q96JG6 | |
| KKLESHLSQEHRRPP | 11 | C9J3V5 | |
| PDLKKHERVHSNERP | 346 | O43829 | |
| FKLPPHISLHRIVDK | 121 | Q9NYT0 | |
| SVHSPHKPALKLEKV | 506 | Q9NX65 | |
| PHLKAAHIPENAKDR | 996 | P10745 | |
| EHLDPLLKDAPKHLP | 216 | Q6P1M0 | |
| PVHKIPDSHEITLKH | 166 | Q9NW82 | |
| EKLFQARKHRPKPHL | 486 | Q8TB22 | |
| TEHGKIHLLEPPRKK | 336 | Q8NBB4 | |
| LIPHARSHAREKPFK | 416 | Q9H5H4 | |
| PKLQHLAPEELHTDR | 1806 | O95359 | |
| LIHKHRPDLIDFDKL | 211 | P11277 | |
| IGHLKLEPKRHSTPI | 926 | Q12888 | |
| EKKPDLHALHNSLSP | 1316 | O43151 | |
| KEIHPDNLGPKHLSR | 451 | A8K0R7 | |
| TKHREVHVREKPLPH | 931 | Q63HK3 | |
| HSLKVHGKALTLPRP | 2101 | Q96JM2 | |
| HIENSKLPKHLRRPE | 121 | Q6S9Z5 | |
| GKPFKHPSNLELHKR | 401 | Q6ZSB9 | |
| AKHRRVPLADKPHEK | 161 | P36406 | |
| LEEPLEPKRELSHHA | 626 | Q6UX68 | |
| DHSPSRKLPEIQHPK | 511 | Q9Y6X0 | |
| HAAVHSRDRKKRPDP | 541 | Q9H4Z2 | |
| DHGVPEDPHLLLKLR | 821 | P08575 | |
| TKTGLRPDHRPDHKL | 301 | Q96PF2 | |
| RPDHRPDHKLGAKTQ | 306 | Q96PF2 | |
| DLLHPSPEEEKRKHK | 6 | P42677 | |
| LSRIHHDQPVKPLDR | 446 | O75795 | |
| HLKGALKEPIHIPKT | 1596 | O75962 | |
| RLSRIHHDQPVKPLD | 451 | P0DTE5 | |
| HRSKSHPALLLAPQE | 466 | Q9BU19 | |
| RSPHAAHLKKLDLSG | 331 | Q15048 | |
| HLDPKTKELPHLRNP | 51 | Q9Y4I1 | |
| AELPTHPSKKRKHSE | 246 | Q9Y2G1 |